(Total Views: 890)
Posted On: 09/30/2020 2:39:37 PM
Post# of 155042
From an earlier post of mine.
If the 10% (13 patients) is even a bit close there is no way we don't seek approval on interim.
Quote:
I think worst case scenario there's a 25% mortality rate in SOC and a 10% mortality rate for leronlimab.
The 25% worst case scenario was based on the Dexamethasone's 25% mortality in non-invasive oxygen.
If the 10% (13 patients) is even a bit close there is no way we don't seek approval on interim.
(11)
(0)
